1-(6-butoxy-2,3-dihydrochromen-4-ylideneamino)-3-(4-(piperidin-1-yl)butyl)imidazolidine-2,4-dione

ID: ALA475725

Chembl Id: CHEMBL475725

Max Phase: Preclinical

Molecular Formula: C25H36N4O4

Molecular Weight: 456.59

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCCCOc1ccc2c(c1)/C(=N/N1CC(=O)N(CCCCN3CCCCC3)C1=O)CCO2

Standard InChI:  InChI=1S/C25H36N4O4/c1-2-3-16-32-20-9-10-23-21(18-20)22(11-17-33-23)26-29-19-24(30)28(25(29)31)15-8-7-14-27-12-5-4-6-13-27/h9-10,18H,2-8,11-17,19H2,1H3/b26-22+

Standard InChI Key:  QNGOGRWIZKPKHV-XTCLZLMSSA-N

Alternative Forms

1. Parent:

   

   ALA475725

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 456.59

Molecular Weight (Monoisotopic): 456.2737

AlogP: 3.88

#Rotatable Bonds: 10

Polar Surface Area: 74.68

Molecular Species: BASE

HBA: 6

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.95

CX Basic pKa: 9.57

CX LogP: 3.15

CX LogD: 1.00

Aromatic Rings: 1

Heavy Atoms: 33

QED Weighted: 0.39

Np Likeness Score: -0.84

References

1. Du L, Li M, Yang Q, Tang Y, You Q, Xia L..  (2009)  Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers.,  19  (5): [PMID:19185489] [10.1016/j.bmcl.2009.01.022]

Source

Source(1):

• Scientific Literature